Publication Date
In 2025 | 0 |
Since 2024 | 0 |
Since 2021 (last 5 years) | 2 |
Since 2016 (last 10 years) | 2 |
Since 2006 (last 20 years) | 4 |
Descriptor
Author
Publication Type
Journal Articles | 4 |
Reports - Research | 4 |
Education Level
Audience
Laws, Policies, & Programs
Assessments and Surveys
Childhood Autism Rating Scale | 4 |
Aberrant Behavior Checklist | 1 |
Conners Rating Scales | 1 |
Conners Teacher Rating Scale | 1 |
Vineland Adaptive Behavior… | 1 |
What Works Clearinghouse Rating
Miot, Stéphanie; Chancel, Raphaël; Peries, Marianne; Crepiat, Sophie; Couderc, Sylvie; Pernon, Eric; Picot, Marie-Christine; Gonnier, Véronique; Jeandel, Claude; Blain, Hubert; Baghdadli, Amaria – Autism: The International Journal of Research and Practice, 2023
Multimorbidity, defined as having two or more chronic health conditions, is associated with elevated polypharmacy and mortality. Autism spectrum disorder is a whole-body chronic health condition in which comorbidities -- in particular co-occurring intellectual disability -- contribute to high clinical heterogeneity, polypharmacy and premature…
Descriptors: Comorbidity, Adults, Autism Spectrum Disorders, Intellectual Disability
Savage, Melissa N.; Tomaszewski, Brianne T.; Hume, Kara A. – Focus on Autism and Other Developmental Disabilities, 2022
Adults with autism spectrum disorder and intellectual disability often do not engage in healthy levels of physical activity despite its many benefits. We conducted a randomized control trial to evaluate the effectiveness and feasibility of the Step It Up program, which used supported self-management strategies, on daily step counts, health…
Descriptors: Measurement Equipment, Autism Spectrum Disorders, Intervention, Comparative Analysis
Fernandez-Jaen, Alberto; Fernandez-Mayoralas, Daniel Martin; Calleja-Perez, Beatriz; Munoz-Jareno, Nuria; Campos Diaz, Maria del Rosario; Lopez-Arribas, Sonia – Journal of Attention Disorders, 2013
Objective: Atomoxetine's tolerance and efficacy were studied in 24 patients with pervasive developmental disorder and symptoms of ADHD. Method: Prospective, open-label, 16-week study was performed, using the variables of the Clinical Global Impression Scale and the Conners' Scale, among others. Results: A significant difference was found between…
Descriptors: Drug Therapy, Attention Deficit Hyperactivity Disorder, Symptoms (Individual Disorders), Pervasive Developmental Disorders
Charnsil, Chawanun – Journal of Attention Disorders, 2011
Objective: This study aims to examine the efficacy of atomoxetine in treating symptoms of attention deficit hyperactivity disorder (ADHD) in children with severe autistic disorder. Method: Children with severe autistic disorder who had symptoms of ADHD were given atomoxetine for 10 weeks. The efficacy of atomoxetine was evaluated by using the…
Descriptors: Attention Deficit Hyperactivity Disorder, Drug Therapy, Severe Disabilities, Pervasive Developmental Disorders